The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.5, 2010-05, pp. : 773-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Certolizumab pegol in rheumatoid arthritis: current update

By Fechtenbaum Marie Md Yusof Md Yuzaiful Emery Paul

Expert Opinion on Biological Therapy, Vol. 14, Iss. 6, 2014-06 ,pp. : 841-850

Informa Healthcare

Access to resources Recommend Favorite

CDP-870 (certolizumab) in rheumatoid arthritis

By Kaushik V Moots RJ

Expert Opinion on Biological Therapy, Vol. 5, Iss. 4, 2005-04 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite

Certolizumab pegol in the treatment of Crohn's disease

By Ferrante Marc Vermeire Séverine Rutgeerts Paul

Expert Opinion on Biological Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 595-605

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of golimumab in the treatment of arthritis

By Fleischmann Roy

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1131-1143

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for rheumatoid arthritis

By Ghivizzani Steven C Gouze Elvire Gouze Jean-Noel Palmer Glyn D Evans Christopher H Robbins Paul D

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 971-978

Informa Healthcare

Access to resources Recommend Favorite